Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
23.15
-0.37 (-1.57%)
At close: Jun 27, 2025, 4:00 PM
24.07
+0.92 (3.97%)
After-hours: Jun 27, 2025, 7:30 PM EDT

Janux Therapeutics Statistics

Total Valuation

JANX has a market cap or net worth of $1.37 billion. The enterprise value is $378.37 million.

Market Cap 1.37B
Enterprise Value 378.37M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date Aug 6, 2025
Ex-Dividend Date n/a

Share Statistics

JANX has 59.18 million shares outstanding. The number of shares has increased by 24.21% in one year.

Current Share Class 59.18M
Shares Outstanding 59.18M
Shares Change (YoY) +24.21%
Shares Change (QoQ) +8.73%
Owned by Insiders (%) 6.63%
Owned by Institutions (%) 85.73%
Float 37.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 138.56
Forward PS 1,740.96
PB Ratio 1.33
P/TBV Ratio 1.35
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 40.53
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 58.47, with a Debt / Equity ratio of 0.02.

Current Ratio 58.47
Quick Ratio 58.26
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -9.32% and return on invested capital (ROIC) is -8.28%.

Return on Equity (ROE) -9.32%
Return on Assets (ROA) -8.16%
Return on Invested Capital (ROIC) -8.28%
Return on Capital Employed (ROCE) -10.99%
Revenue Per Employee $115,259
Profits Per Employee -$959,778
Employee Count 81
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -41.83% in the last 52 weeks. The beta is 2.95, so JANX's price volatility has been higher than the market average.

Beta (5Y) 2.95
52-Week Price Change -41.83%
50-Day Moving Average 26.28
200-Day Moving Average 39.88
Relative Strength Index (RSI) 41.07
Average Volume (20 Days) 701,303

Short Selling Information

The latest short interest is 10.61 million, so 17.93% of the outstanding shares have been sold short.

Short Interest 10.61M
Short Previous Month 10.67M
Short % of Shares Out 17.93%
Short % of Float 28.63%
Short Ratio (days to cover) 11.13

Income Statement

In the last 12 months, JANX had revenue of $9.34 million and -$77.74 million in losses. Loss per share was -$1.37.

Revenue 9.34M
Gross Profit -70.04M
Operating Income -113.58M
Pretax Income -44.05M
Net Income -77.74M
EBITDA -111.54M
EBIT -113.58M
Loss Per Share -$1.37
Full Income Statement

Balance Sheet

The company has $1.01 billion in cash and $22.61 million in debt, giving a net cash position of $991.53 million or $16.76 per share.

Cash & Cash Equivalents 1.01B
Total Debt 22.61M
Net Cash 991.53M
Net Cash Per Share $16.76
Equity (Book Value) 1.01B
Book Value Per Share 17.11
Working Capital 1.01B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$46.00 million and capital expenditures -$533,000, giving a free cash flow of -$46.53 million.

Operating Cash Flow -46.00M
Capital Expenditures -533,000
Free Cash Flow -46.53M
FCF Per Share -$0.79
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,216.61%
Pretax Margin -832.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -24.21%
Shareholder Yield -24.21%
Earnings Yield -5.67%
FCF Yield -3.40%

Analyst Forecast

The average price target for JANX is $94.29, which is 307.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target $94.29
Price Target Difference 307.30%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 98.97%
EPS Growth Forecast (5Y) -20.89%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

JANX has an Altman Z-Score of 38.66 and a Piotroski F-Score of 1.

Altman Z-Score 38.66
Piotroski F-Score 1